# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-22-001029
Filing Date
2022-01-10
Accepted
2022-01-10 08:53:21
Documents
41
Period of Report
2022-01-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | brhc10032676_8k.htm iXBRL | 8-K | 29769
2 | EXHIBIT 99.1 | brhc10032676_ex99-1.htm | EX-99.1 | 52767
6 |  | brhc10032676_ex99-1slide1.jpg | GRAPHIC | 106938
7 |  | brhc10032676_ex99-1slide2.jpg | GRAPHIC | 374030
8 |  | brhc10032676_ex99-1slide3.jpg | GRAPHIC | 189938
9 |  | brhc10032676_ex99-1slide4.jpg | GRAPHIC | 209726
10 |  | brhc10032676_ex99-1slide5.jpg | GRAPHIC | 172142
11 |  | brhc10032676_ex99-1slide6.jpg | GRAPHIC | 141363
12 |  | brhc10032676_ex99-1slide7.jpg | GRAPHIC | 176754
13 |  | brhc10032676_ex99-1slide8.jpg | GRAPHIC | 190474
14 |  | brhc10032676_ex99-1slide9.jpg | GRAPHIC | 180259
15 |  | brhc10032676_ex99-1slide10.jpg | GRAPHIC | 153625
16 |  | brhc10032676_ex99-1slide11.jpg | GRAPHIC | 155419
17 |  | brhc10032676_ex99-1slide12.jpg | GRAPHIC | 175985
18 |  | brhc10032676_ex99-1slide13.jpg | GRAPHIC | 201975
19 |  | brhc10032676_ex99-1slide14.jpg | GRAPHIC | 174298
20 |  | brhc10032676_ex99-1slide15.jpg | GRAPHIC | 188329
21 |  | brhc10032676_ex99-1slide16.jpg | GRAPHIC | 163291
22 |  | brhc10032676_ex99-1slide17.jpg | GRAPHIC | 143612
23 |  | brhc10032676_ex99-1slide18.jpg | GRAPHIC | 164743
24 |  | brhc10032676_ex99-1slide19.jpg | GRAPHIC | 165432
25 |  | brhc10032676_ex99-1slide20.jpg | GRAPHIC | 228251
26 |  | brhc10032676_ex99-1slide21.jpg | GRAPHIC | 164094
27 |  | brhc10032676_ex99-1slide22.jpg | GRAPHIC | 141459
28 |  | brhc10032676_ex99-1slide23.jpg | GRAPHIC | 74202
29 |  | brhc10032676_ex99-1slide24.jpg | GRAPHIC | 190774
30 |  | brhc10032676_ex99-1slide25.jpg | GRAPHIC | 149595
31 |  | brhc10032676_ex99-1slide26.jpg | GRAPHIC | 93521
32 |  | brhc10032676_ex99-1slide27.jpg | GRAPHIC | 181978
33 |  | brhc10032676_ex99-1slide28.jpg | GRAPHIC | 163533
| Complete submission text file | 0001140361-22-001029.txt |  | 6866603

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | plrx-20220110.xsd | EX-101.SCH | 3923
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | plrx-20220110_lab.xml | EX-101.LAB | 22544
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | plrx-20220110_pre.xml | EX-101.PRE | 16042
35 | EXTRACTED XBRL INSTANCE DOCUMENT | brhc10032676_8k_htm.xml | XML | 4081

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 22519890
SIC: 2834 Pharmaceutical Preparations